CollPlant Biotechnologies (CLGN) Accumulated Depreciation & Amortization (2019 - 2025)

CollPlant Biotechnologies' Accumulated Depreciation & Amortization history spans 7 years, with the latest figure at $7.9 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 12.16% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $7.9 million, up 12.16%, while the annual FY2025 figure was $7.9 million, 12.16% up from the prior year.
  • Accumulated Depreciation & Amortization reached $7.9 million in Q4 2025 per CLGN's latest filing, up from $7.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $8.7 million in Q4 2023 to a low of $773000.0 in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $5.1 million, with a median of $7.0 million recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 744.5% in 2023, then fell 19.72% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $773000.0 in 2021, then soared by 34.02% to $1.0 million in 2022, then soared by 744.5% to $8.7 million in 2023, then fell by 19.72% to $7.0 million in 2024, then increased by 12.16% to $7.9 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Accumulated Depreciation & Amortization are $7.9 million (Q4 2025), $7.0 million (Q4 2024), and $8.7 million (Q4 2023).